BridgeBio Pharma Inc. (BBIO)
NASDAQ: BBIO
· Real-Time Price · USD
51.30
0.12 (0.23%)
At close: Aug 15, 2025, 3:59 PM
51.32
0.04%
After-hours: Aug 15, 2025, 04:10 PM EDT
BridgeBio Pharma Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 749.4M | 540.6M | 681.1M | 266.32M | 407.96M | 475.35M | 375.94M | 505.21M | 302.44M | 407.37M | 376.69M | 483.24M | 470.1M | 371.55M | 393.77M | 180.35M | 378.42M | 471.18M |
Short-Term Investments | 7.94M | n/a | n/a | n/a | 39.81M | 44.47M | 58.95M | 38.05M | 333.31M | 34.12M | 95.23M | 108.74M | 245.61M | 299.68M | 442.89M | 419.26M | 459.24M | 447.94M |
Long-Term Investments | 109.7M | 128.19M | 143.75M | 160.44M | 119.15M | 3.94M | 3.74M | 38.05M | 50.49M | 49.8M | 43.65M | 11.61M | 2.41M | 2.47M | 49.15M | 17.71M | 18.89M | 82.2M |
Other Long-Term Assets | 16.41M | 144.8M | 18.2M | 20.29M | 16.76M | 16.78M | 22.63M | 18.68M | 20.4M | 20.77M | 20.22M | 29.87M | 31.32M | 32.86M | 33.03M | 33.05M | 49.8M | 30.18M |
Receivables | 76.87M | 115.27M | 4.72M | 478K | 660K | 235.49M | 1.75M | 5.17M | 8.61M | 10.76M | 17.08M | 24.58M | 22.82M | 10.98M | 19.75M | 8.17M | 1.21M | 462K |
Inventory | 18.28M | 3.95M | n/a | n/a | n/a | n/a | 16.65M | 16.65M | 19.93M | 25.5M | 37.93M | n/a | n/a | n/a | n/a | n/a | 1.21M | n/a |
Other Current Assets | 59.79M | 35.35M | 34.87M | 177.78M | 139.41M | 131K | 27.65M | 16.65M | 19.93M | 25.5M | 37.93M | n/a | n/a | n/a | 177K | n/a | 44.5M | n/a |
Total Current Assets | 912.28M | 695.17M | 720.69M | 444.58M | 616.24M | 783.42M | 477.59M | 549.62M | 382.4M | 502.9M | 505.2M | 642.22M | 771.28M | 716.23M | 839.71M | 639.71M | 970.56M | 945.11M |
Property-Plant & Equipment | 12.29M | 13.86M | 12.78M | 15.14M | 17.11M | 19.47M | 19.84M | 21.75M | 22.86M | 24.1M | 25.25M | 27.34M | 29.72M | 31.12M | 45.97M | 44.85M | 42.24M | 35.81M |
Goodwill & Intangibles | 29.51M | 27.8M | 23.93M | 24.52M | 25.12M | 25.72M | 26.32M | 26.92M | 27.52M | 28.11M | 28.71M | 29.31M | 29.91M | 30.48M | 44.93M | 46.2M | n/a | n/a |
Total Long-Term Assets | 167.91M | 186.47M | 198.65M | 220.4M | 178.14M | 65.91M | 68.79M | 105.39M | 121.26M | 122.78M | 117.84M | 86.52M | 90.95M | 96.92M | 173.08M | 141.81M | 110.93M | 148.19M |
Total Assets | 1.08B | 881.64M | 919.34M | 664.98M | 794.38M | 849.33M | 546.38M | 655.01M | 503.66M | 625.68M | 623.04M | 728.74M | 862.23M | 813.15M | 1.01B | 781.52M | 1.08B | 1.09B |
Account Payables | 26.13M | 27.52M | 9.62M | 13.36M | 18.13M | 4.73M | 10.65M | 4.47M | 3.87M | 4.08M | 11.56M | 10.16M | 8.79M | 10.11M | 11.88M | 12.04M | 22.33M | 10.34M |
Deferred Revenue | 10.54M | 11.62M | 14.6M | 11.77M | 15.1M | 13.96M | 6.1M | 6.59M | 6.21M | 6.67M | 8.16M | 7.52M | 7.19M | n/a | n/a | n/a | -4.54M | n/a |
Short-Term Debt | 9.59M | n/a | n/a | n/a | 4.62M | 4.54M | 4.13M | n/a | 3.78M | 3.67M | n/a | n/a | 4.31M | 4.36M | n/a | n/a | n/a | 7.45M |
Other Current Liabilities | 90.3M | 79.51M | 58.33M | 43.54M | 62.84M | 81.31M | 61.47M | 57.13M | 63.79M | 59.63M | 66.78M | 72.63M | 83.95M | 69.17M | 1.5M | 3.5M | 21.86M | 52.39M |
Total Current Liabilities | 175.85M | 152.1M | 154.4M | 139.22M | 134.36M | 141.48M | 143.84M | 101.93M | 106.34M | 92.92M | 117.75M | 119.19M | 141.16M | 103.46M | 130.13M | 95.82M | 127.37M | 94.73M |
Long-Term Debt | 2.66B | 1.85B | 1.72B | 1.72B | 1.72B | 1.72B | 1.73B | 1.72B | 1.72B | 1.71B | 1.71B | 1.7B | 1.69B | 1.71B | 1.7B | 1.38B | 1.37B | 1.36B |
Other Long-Term Liabilities | 545K | 2.36B | 479.38M | 377K | 485K | 595K | 9.36M | 11.79M | 13.33M | 17.5M | 26.64M | 28.23M | 28.63M | 26.83M | 22.07M | 26.25M | 11.85M | 11.61M |
Total Long-Term Liabilities | 2.68B | 2.37B | 2.22B | 1.74B | 1.74B | 1.74B | 1.75B | 1.75B | 1.75B | 1.75B | 1.75B | 1.74B | 1.74B | 1.75B | 1.75B | 1.42B | 1.41B | 1.39B |
Total Liabilities | 2.86B | 2.52B | 2.38B | 1.88B | 1.88B | 1.89B | 1.89B | 1.85B | 1.85B | 1.84B | 1.87B | 1.86B | 1.88B | 1.85B | 1.88B | 1.52B | 1.54B | 1.48B |
Total Debt | 2.68B | 1.86B | 1.73B | 1.73B | 1.73B | 1.73B | 1.74B | 1.74B | 1.73B | 1.73B | 1.72B | 1.72B | 1.71B | 1.73B | 1.73B | 1.4B | 1.4B | 1.38B |
Common Stock | 198K | 197K | 196K | 195K | 194K | 193K | 181K | 180K | 168K | 167K | 157K | 156K | 154K | 154K | 154K | 153K | 153K | 152K |
Retained Earnings | -3.45B | -3.26B | -3.1B | -2.83B | -2.67B | -2.6B | -2.56B | -2.39B | -2.22B | -2.06B | -1.92B | -1.78B | -1.64B | -1.63B | -1.44B | -1.29B | -1.13B | -1.04B |
Comprehensive Income | 1K | n/a | 8K | 5K | -4K | 2K | 31K | 34K | 63K | -12K | -328K | -348K | -427K | -383K | -132K | 19K | 36K | -57K |
Shareholders Equity | -1.79B | -1.64B | -1.47B | -1.23B | -1.09B | -1.05B | -1.35B | -1.21B | -1.36B | -1.23B | -1.25B | -1.14B | -1.03B | -1.04B | -870.41M | -743.4M | -464.29M | -395.29M |
Total Investments | 117.64M | 128.19M | 143.75M | 160.44M | 158.96M | 48.41M | 58.95M | 38.05M | 333.31M | 34.12M | 138.89M | 108.74M | 245.61M | 299.68M | 442.89M | 436.97M | 538.83M | 530.14M |